Anogenital distribution of mucosal HPV in males and females before and after renal transplantation - 25/01/24
, Antoine Touzé d, Lionel Pazart c, Guillaume Boiteux c, Véronique Fournier e, Chrystelle Vidal c, Françoise Arnold d, Didier Ducloux f, Quentin Lepiller a, b, Christiane Mougin b, fHighlights |
• | Immunosupressive drugs taken by renal transplant recipient may favor HPV infection. |
• | HPV prevalence is high at anogenital sites in both males and females before and after transplantation. |
• | The screening of HPV-associated diseases is mandatory in renal transplant recipients. |
Abstract |
Introduction |
Immunosuppressive drugs taken by transplant recipients may favor HPV infection at anogenital sites. HPV-type prevalence was studied in males and females before and after renal transplantation.
Patients and methods |
Anal, cervical and penile samples were taken from 62 patients before transplantation and from 41 patients after transplantation. HPV DNA was investigated using the INNO-LiPA HPV genotyping extra test and HPV-type distribution determined.
Results |
Before transplantation, up to 30% of analyzed samples harbored HPV DNA, with the highest prevalence found in cervical specimens (60%). After transplantation, a trend toward HPV clearance was observed in females. By contrast, a trend toward incident infections by a wide variety of HPV genotypes at the penis and anal level was documented in men.
Conclusion |
High prevalence of HPV at anogenital sites was documented before and after renal transplantation. Immunosuppressive drugs taken after transplantation may impact HPV acquisition or reactivation, especially in males. Special attention should be paid in view of preventing HPV-associated diseases in this vulnerable population.
Le texte complet de cet article est disponible en PDF.Keywords : Anus, Cervix, Papillomavirus, Penis, Renal transplant
Plan
Vol 54 - N° 1
Article 104830- février 2024 Retour au numéro
Article précédent
- Length of stay in at-risk areas and time to malaria attack on return
- Salomé Gallet, Céline Dard, Sébastien Bailly, Marc Thellier, Sandrine Houze, Hervé Pelloux, Olivier Epaulard
- The effects of switching from ceftriaxone to cefotaxime on the occurrence of third-generation cephalosporin-resistant Enterobacterales: A stepped-wedge cluster randomized trial
- Kevin Bouiller, Houssein Gbaguidi-Haore, Didier Hocquet, Thomas Crépin, Daniel Wendling, Sophie Borot, Catherine Chirouze, Xavier Bertrand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?